Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue August 2014
 •  Innovations in Dermatological Sciences  •  Maybelline Teams Up With Made  •  Purell on Campus  •  The Next Multifunctional Ingredient  •  Urban Decay Adds On To ‘Naked’ Empire
Print

Dermatology Drug Market To Grow 8% a Year to 2008



Published November 22, 2005
Related Searches: dermatology gel men treatment
Post a comment
The Dermatology Drug market will grow 8% a year to 2008, led by demand for psoriasis treatments, according to the “Dermatology pipeline analysis: a market with room to grow” report by Decision Resources (DR), Waltham, MA. This is largely due to the Food and Drug Administration’s approval of Enbrel, an Amgen-based treatment for adults with moderate-to-severe chronic plaque psoriasis. Medications for atopic dermatitis will also increase, but uticario medications will decline.


blog comments powered by Disqus